Form 4: UroGen Pharma Executive Jason Smith Reports Stock Transactions
SEC Form 4 Filing
Jason Smith, General Counsel of UroGen Pharma Ltd., reports the acquisition and disposal of ordinary shares and restricted stock units.
Summary
- Jason Smith, General Counsel of UroGen Pharma Ltd., filed a Form 4 detailing changes in beneficial ownership.
- On September 9, 2024, Smith acquired 3,333 ordinary shares through the vesting of restricted stock units (RSUs).
- Also on September 9, 2024, Smith disposed of 1,521 ordinary shares at a price of $13.08 to satisfy withholding tax obligations related to the RSU settlement.
- Following these transactions, Smith beneficially owns 25,226 ordinary shares directly and 6,667 restricted stock units.
- The RSUs were granted on September 7, 2023, and vest in three equal annual installments from September 7, 2024.
Sentiment
Score: 5
Explanation: This is a neutral reporting of stock transactions by an insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It's standard practice for executives to sell shares to cover tax obligations when RSUs vest.
Stakeholder Impact
- The transactions have a minimal impact on shareholders, as they represent a small portion of the outstanding shares.
- The sale of shares to cover tax obligations is a standard practice and does not reflect a change in the executive's long-term outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 09/07/2023 | Date the reporting person was granted RSUs representing 10,000 ordinary shares |
| 09/09/2024 | Date of transaction: acquisition of 3,333 ordinary shares via RSU vesting and disposal of 1,521 shares for tax obligations. |
| 09/07/2024 | Date the RSUs will vest in three equal annual installments from |
| 09/12/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.